• News from ISSCR website tile
  • 18 August, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR Statement on the NIH Human Fetal Tissue Research Ethics Advisory Board Meeting

  • 4 August, 2020
  • 8/4/2020 4:00:00 AM

    Full story
  • News from ISSCR website tile

    ISSCR Statement on Proposed Cuts to Scientific Research in Europe

  • 15 July, 2020
  • Full story
  • News from ISSCR website tile

    The ISSCR Signs Two Letters Opposing U.S. Administration’s Immigration Policies

  • 13 July, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR Urges FDA and EMA to Enforce Regulation of Clinics Offering Unproven and Unapproved Stem Cell-based Interventions

  • 24 June, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR Shares Recommendations for Proposed Genome Editing Registry with WHO

  • 11 May, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR and 100 Scientific Organizations Urge the Administration to Lift the Restrictions on Fetal Tissue Research

  • 25 March, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR Announces Endorsement for California Initiative to Fund Stem Cell Research ​

  • 20 March, 2020
  • Full story
  • News from ISSCR website tile

    ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products

  • 16 March, 2020
  • The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.
    Full story
  • News from ISSCR website tile

    ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse

  • 16 March, 2020
  • The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.
    Full story
  • embryo image

    ISSCR Statement on Ethical Standards for Stem Cell-based Embryo Models

  • 16 January, 2020
  • The ISSCR is updating its Guidelines for Stem Cell Research and Clinical Translation to respond to recent scientific advances that include the use of pluripotent stem cell (PSC) to create models of early human embryo development.
    Full story
  • Deepak

    The “I” in the ISSCR

  • 15 January, 2020
  • The International Society for Stem Cell Research (ISSCR) is just that, an international organization. We work across the globe to promote excellence in stem cell science and applications to human health. The society advances international initiatives including: policy and advocacy, professional standards, building working relationships to stay abreast of emerging areas of interest, and of course educational meetings.
    Full story
  • The ISSCR Hosts Ethics Workshop in China

  • 9 January, 2020
  • The ISSCR and the Guangzhou Institute of Biomedicine and Health held a two-day workshop in Guangzhou, China. A small group of scientists and ethicists from around the world met to discuss ethical, scientific, and societal challenges in regenerative medicine.
    Full story
  • The ISSCR is Updating its Guidelines

  • 9 December, 2019
  • Stem cell science, its clinical application, and the ethical issues surrounding it have rapidly advanced since the release of the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation. The latest update will address important scientific, ethical, and regulatory issues, including embryo models, organoids, chimeras, genome editing, and the regulation and economics of cell therapies.
    Full story
  • ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation

  • 10 October, 2019
  • The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”
    Full story
  • Lawrence Goldstein Policy Fellows Announced

  • 8 October, 2019
  • The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).
    Full story
  • ISSCR Policy Advocacy in Action

  • 7 October, 2019
  • Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.
    Full story
    View All ISSCR News